lawsuits against glp 1 Ozempic Lawsuit: July 2026 Blindness and Gastroparesis Claims Trulicity Lawsuit - July 2026

Currently, there are 20 oligonucleotide drugs approved by the FDA and the European Medicines Agency (EMA) and a majority of them treat orphan and rare diseases.In 2023, FDA approved four ONTs AstraZeneca-Ionis Wainua (eplontersen), Novo Nordisk owned Dicerna Pharmaceuticals Rivfloza (nedosiran), Biogen-Ionis Qalsody (tofersen) and Iveric Bios Izervay (avacincaptad pegol).In 2021, the global ONT market size was estimated to be US$ 18.2 billion

The pathophysiology of gastroparesis involves impaired motility of the stomach, resulting from dysfunction of the autonomic nerves, smooth muscle abnormalities, or disruptions in the enteric nervous system [2]

These findings might lay the foundation for the potential regenerative treatment of patients with chronic stroke

They cannot make medical claims and have not undergone the same rigorous testing as prescription medications

J.LaneM